What Canadians Should Know About Every Authorized COVID-19 Vaccine – fr

0
14
What Canadians Should Know About Every Authorized COVID-19 Vaccine – fr


TORONTO – Canada expects to receive more than two million doses of the Pfizer-BioNTech COVID-19 vaccine each week through June, and one million more doses of Moderna next week. With four COVID-19 vaccines now authorized in Canada, who will become eligible to receive which vaccines and where can they get them?

The COVID-19 vaccines approved for use in Canada so far are Pfizer-BioNTech, Moderna, AstraZeneca, and Johnson & Johnson. To date, over 14 million doses have been administered across the country. With Canada set to receive large dose shipments in the coming weeks, CTVNews.ca has indicated which groups are recommended to be eligible to receive which vaccines, where they can get them and how many doses Canada has received. to date and will receive in the future.

Eligibility decisions are made at the provincial level, informed by recommendations from the National Advisory Committee on Immunization (NACI).

PFIZER-BIONTECH

Health Canada authorized the Pfizer vaccine on December 9, 2020, making it the first vaccine approved in Canada to prevent COVID-19. The two-dose mRNA vaccine has been licensed for Canadians 16 years of age and older and has been available in hospitals, mass immunization clinics and pop-up clinics.

The government began distributing doses of the Pfizer vaccine in December 2020, and last week more than 9.5 million doses were distributed across the country. While Canada received just over one million doses each week in April, the supply will double, with Canada receiving more than two million doses per week until early July, giving the government a boost. inch to reach its goal of vaccinated adults at the end of September. With the arrival of doses, NACI said the four-month waiting period before the first and second doses could even drop to a 1.5- to two-month waiting period.

So far, the government has invested in up to 76 million doses of the Pfizer COVID-19 vaccine.

MODERN

The Moderna mRNA vaccine was authorized on December 23, 2020 by Health Canada for people aged 18 and over. Similar to Pfizer, the two-dose vaccine has been offered at local hospitals, mass vaccination clinics, and pop-up clinics.

Shipments of Moderna vaccine arrived a day after Health Canada approval and were first distributed in Canada’s North. As of last week, nearly 2.9 million doses of Moderna have been allocated across the country, with Canada expecting to receive around one million more doses next week.

Currently, the government has secured an agreement with the pharmaceutical company for 44 million doses.

ASTRAZENECA

The AstraZeneca vaccine – scientifically known as ChAdOx1-S – is manufactured by AstraZeneca as well as the Serum Institute of India, which calls its vaccine brand COVISHIELD. The vaccine and the two manufacturers were approved by Health Canada on February 26. The adenovirus vector vaccine is given in two doses, and although the vaccine was first licensed for Canadians 18 years of age and older, NACI has made recommendations on the age group should receive this vaccine. AstraZeneca was initially recommended to Canadians over 65 in March, but NACI has now increased eligibility to include more Canadians and now recommends the vaccine to anyone aged 30 and over, if they don’t want to wait. an mRNA vaccine.

The vaccine is currently available in pharmacies, with many places offering walk-in appointments and making COVID-19 vaccines more accessible to Canadians.

The AstraZeneca vaccine was first distributed in Canada in March, and last week approximately 2.3 million doses were distributed across the country. With the exception of the Northwest Territories and Nunavut, all provinces and territories have received shipments of this vaccine.

With the two manufacturers combined, the government obtained a total of 22 million doses of AstraZeneca.

JOHNSON & JOHNSON

Johnson & Johnson’s COVID-19 vaccine was cleared by Health Canada on March 5. This is a single dose adenovirus vector vaccine. The vaccine has been approved for Canadians aged 18 and over, but like NACI’s suggestions with AstraZeneca, the Johnson & Johnson vaccine is recommended for those aged 30 and over and for people who do not wish to wait for a mRNA vaccine.

NACI also recommended using the single dose vaccine for populations where it may be more difficult to schedule a second dose. Experts say this could include people living in shelters or experiencing homelessness, and adding a single-dose vaccine could also create more pop-up clinics.

Last Wednesday, a shipment of 300,000 doses of Johnson & Johnson arrived in Canada, but Health Canada has since held the doses due to possible quality control issues and no vaccine is currently available to Canadians.

For Johnson & Johnson, the government has agreed to purchase up to 38 million doses of the vaccine from the manufacturer.

OTHER VACCINES

Although the vaccines have not yet been approved by Health Canada, the government has invested in three other two-dose COVID-19 vaccine suppliers: Medicago, Novavax and Sanofi and GlaxoSmithKline. The government has agreed to purchase up to 76 million doses of each of the Medicago and Novavax vaccines and up to 72 million doses of the Sanofi and GlaxoSmithKline vaccines, if their use is permitted here.

LEAVE A REPLY

Please enter your comment!
Please enter your name here